These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 22095644)

  • 101. Binding of N-terminal fragments of anthrax edema factor (EF(N)) and lethal factor (LF(N)) to the protective antigen pore.
    Leuber M; Kronhardt A; Tonello F; Dal Molin F; Benz R
    Biochim Biophys Acta; 2008 Jun; 1778(6):1436-43. PubMed ID: 18243126
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Cys-Cys cross-linking shows contact between the N-terminus of lethal factor and Phe427 of the anthrax toxin pore.
    Janowiak BE; Jennings-Antipov LD; Collier RJ
    Biochemistry; 2011 May; 50(17):3512-6. PubMed ID: 21425869
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Anthrax toxin channel: What we know based on over 30 years of research.
    Liu W; Nestorovich EM
    Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183715. PubMed ID: 34332985
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Small molecule inhibitors of anthrax lethal factor toxin.
    Williams JD; Khan AR; Cardinale SC; Butler MM; Bowlin TL; Peet NP
    Bioorg Med Chem; 2014 Jan; 22(1):419-34. PubMed ID: 24290062
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Chemical dissection of protein translocation through the anthrax toxin pore.
    Pentelute BL; Sharma O; Collier RJ
    Angew Chem Int Ed Engl; 2011 Mar; 50(10):2294-6. PubMed ID: 21351339
    [No Abstract]   [Full Text] [Related]  

  • 106. Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors.
    Phillips DD; Fattah RJ; Crown D; Zhang Y; Liu S; Moayeri M; Fischer ER; Hansen BT; Ghirlando R; Nestorovich EM; Wein AN; Simons L; Leppla SH; Leysath CE
    J Biol Chem; 2013 Mar; 288(13):9058-65. PubMed ID: 23393143
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Molecular motions as a drug target: mechanistic simulations of anthrax toxin edema factor function led to the discovery of novel allosteric inhibitors.
    Laine E; Martínez L; Ladant D; Malliavin T; Blondel A
    Toxins (Basel); 2012 Aug; 4(8):580-604. PubMed ID: 23012649
    [TBL] [Abstract][Full Text] [Related]  

  • 108. The anthrax toxin channel: a barrel of LFs.
    Blaustein RO
    J Gen Physiol; 2011 Apr; 137(4):337-41. PubMed ID: 21402885
    [No Abstract]   [Full Text] [Related]  

  • 109. Ultrasensitive detection of protein translocated through toxin pores in droplet-interface bilayers.
    Fischer A; Holden MA; Pentelute BL; Collier RJ
    Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16577-81. PubMed ID: 21949363
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Assembly of anthrax toxin pore: lethal-factor complexes into lipid nanodiscs.
    Akkaladevi N; Hinton-Chollet L; Katayama H; Mitchell J; Szerszen L; Mukherjee S; Gogol EP; Pentelute BL; Collier RJ; Fisher MT
    Protein Sci; 2013 Apr; 22(4):492-501. PubMed ID: 23389868
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Empirical valence bond simulations of the chemical mechanism of ATP to cAMP conversion by anthrax edema factor.
    Mones L; Tang WJ; Florián J
    Biochemistry; 2013 Apr; 52(15):2672-82. PubMed ID: 23480863
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Crystal structure of the anthrax toxin protective antigen.
    Petosa C; Collier RJ; Klimpel KR; Leppla SH; Liddington RC
    Nature; 1997 Feb; 385(6619):833-8. PubMed ID: 9039918
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Atomic structure of anthrax protective antigen pore elucidates toxin translocation.
    Jiang J; Pentelute BL; Collier RJ; Zhou ZH
    Nature; 2015 May; 521(7553):545-9. PubMed ID: 25778700
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Ratcheting up protein translocation with anthrax toxin.
    Feld GK; Brown MJ; Krantz BA
    Protein Sci; 2012 May; 21(5):606-24. PubMed ID: 22374876
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.
    Leppla SH
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3162-6. PubMed ID: 6285339
    [TBL] [Abstract][Full Text] [Related]  

  • 116. [Bacillus anthracis: a molecular look at a famous pathogen].
    Pavan ME; Pettinari MJ; Cairó F; Pavan EE; Cataldi AA
    Rev Argent Microbiol; 2011; 43(4):294-310. PubMed ID: 22274828
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Evolving role of seneca valley virus and its biomarker TEM8/ANTXR1 in cancer therapeutics.
    Corbett V; Hallenbeck P; Rychahou P; Chauhan A
    Front Mol Biosci; 2022; 9():930207. PubMed ID: 36090051
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Impact of Bacterial Toxins in the Lungs.
    Lucas R; Hadizamani Y; Gonzales J; Gorshkov B; Bodmer T; Berthiaume Y; Moehrlen U; Lode H; Huwer H; Hudel M; Mraheil MA; Toque HAF; Chakraborty T; Hamacher J
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32252376
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
    Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
    BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
    [TBL] [Abstract][Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.